Evolution of the COVID-19 vaccine development landscape.

@article{Le2020EvolutionOT,
  title={Evolution of the COVID-19 vaccine development landscape.},
  author={Tung Thanh Le and Jakob P. Cramer and Robert T Chen and Stephen Mayhew},
  journal={Nature reviews. Drug discovery},
  year={2020}
}
Tras el brote de una enfermedad por un nuevo coronavirus (COVID-19) que se produjo en Wuhan, una ciudad de la provincia de Hubei en China, se ha registrado una rápida propagación a escala comunitaria, regional e internacional, con un aumento exponencial del número de casos y muertes El 30 de enero del 2020, el Director General de la OMS declaró que el brote de COVID-19 era una emergencia de salud pública de importancia internacional de conformidad con el Reglamento Sanitario Internacional (2005… 
Nuevos mecanismos de colaboración público-privada para el desarrollo y acceso a la vacuna COVID-19: una perspectiva desde la teoría fundamentada
El objetivo de este texto es identificar y caracterizar como ante un hecho global de alto impacto, como puede ser una pandemia, se crean nuevas formas de colaboracion y competencia entre los agentes
COVID-19 et vaccination : une dérégulation globale
La COVID-19 est une infection pandémique émergente dont l’importante capacité à se propager dans une population dénuée d’immunité n’est plus à prouver. La première réponse des États à la flambée de
Comprehensive narrative review of real-world COVID-19 vaccines: viewpoints and opportunities
TLDR
There is a need to establish a unified evaluation standard of vaccine effectiveness, monitor vaccine safety and effectiveness, along with the virological characteristics of SARS-CoV-2 variants, and determine the most useful booster schedule.
COVID-19: Characteristics and Therapeutics
TLDR
It is speculated that the current pandemic emergency will trigger detailed studies of coronaviruses, their mechanism of infection, development of systematic drug repurposing approaches, and novel drug discoveries for current and future pandemic outbreaks.
COVID-19: vaccines, efficacy and effects on variants
TLDR
Three leading strategies of vaccine development against coronavirus disease 2019 (COVID- 19): mRNA vaccines, adenoviral vector vaccines and recombinant nanoparticles are reviewed and the evidence for the effectiveness of the vaccines against those five VoC is explored.
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
TLDR
Full vaccination of COVID-19 vaccines is highly effective against Alpha variant, and moderate effective against Beta, Gamma, and Delta variants, and booster vaccination is more effective against Delta and Omicron variants.
...
...